| editorial | Q871232 |
| scholarly article | Q13442814 |
| P356 | DOI | 10.1080/14760584.2016.1195266 |
| P698 | PubMed publication ID | 27248694 |
| P50 | author | Sylvia van Drunen Littel-van den Hurk | Q89729347 |
| Volker Gerdts | Q96650456 | ||
| P2093 | author name string | Andrew Potter | |
| P2860 | cites work | Effectiveness of maternal pertussis vaccination in England: an observational study. | Q42205386 |
| Novel vaccine formulations against pertussis offer earlier onset of immunity and provide protection in the presence of maternal antibodies | Q42262598 | ||
| Safety and immunogenicity of a Sf9 insect cell-derived respiratory syncytial virus fusion protein nanoparticle vaccine | Q43625547 | ||
| Immune responses in infants whose mothers received Tdap vaccine during pregnancy. | Q43898020 | ||
| Seasonal variation of maternally derived respiratory syncytial virus antibodies and association with infant hospitalizations for respiratory syncytial virus | Q45387257 | ||
| Correlates of immunity to respiratory syncytial virus (RSV) associated-hospitalization: establishment of minimum protective threshold levels of serum neutralizing antibodies | Q45722681 | ||
| Immunogenicity of a new purified fusion protein vaccine to respiratory syncytial virus: a multi-center trial in children with cystic fibrosis | Q45723625 | ||
| Influence of maternal antibodies on active pertussis toxoid immunization of neonatal mice and piglets | Q46326832 | ||
| The relationship between concentration of specific antibody at birth and subsequent response to primary immunization. | Q54433577 | ||
| Maternal immunity provides protection against pertussis in newborn piglets | Q34601948 | ||
| Insights into the regulatory mechanism controlling the inhibition of vaccine-induced seroconversion by maternal antibodies | Q35067373 | ||
| Safety and immunogenicity of tetanus diphtheria and acellular pertussis (Tdap) immunization during pregnancy in mothers and infants: a randomized clinical trial | Q35097262 | ||
| Mechanisms by which maternal antibodies influence infant vaccine responses: review of hypotheses and definition of main determinants | Q35172908 | ||
| Progress in understanding and controlling respiratory syncytial virus: still crazy after all these years | Q35566601 | ||
| Innate immunity of the newborn: basic mechanisms and clinical correlates | Q36800979 | ||
| Prevention of serious respiratory syncytial virus-related illness. II: Immunoprophylaxis | Q37841264 | ||
| Maternal antibodies and infant immune responses to vaccines | Q38563384 | ||
| Global, regional, and national causes of child mortality in 2000-13, with projections to inform post-2015 priorities: an updated systematic analysis | Q39119101 | ||
| Safety and immunogenicity of respiratory syncytial virus purified fusion protein-2 vaccine in pregnant women | Q40555244 | ||
| Maternal immunization with respiratory syncytial virus fusion protein formulated with a novel combination adjuvant provides protection from RSV in newborn lambs | Q40890942 | ||
| P577 | publication date | 2016-06-01 | |
| P1433 | published in | Expert Review of Vaccines | Q15756339 |
| P1476 | title | Protection of neonates and infants by maternal immunization |
| Q64061950 | Factors associated with recruitment, surveillance participation, and retention in an observational study of pregnant women and influenza |
| Q29248088 | Influenza and respiratory syncytial virus in infants study (IRIS) of hospitalized and non-ill infants aged <1 year in four countries: study design and methods |
| Q63247527 | Overcoming Barriers and Identifying Opportunities for Developing Maternal Immunizations: Recommendations From the National Vaccine Advisory Committee |
Search more.